Ten-Year Breast Cancer Survival Improved In Past 60 Years, MD Anderson Study Finds
Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival
Racial Disparities Remain In Breast Cancer Care
DCIS With Higher Density May Increase Risk For Disease
Choice Of Reconstruction Can Depend On Who Consults
Only 20% of Doctors Advise CRC According To Guidelines
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ









